These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators. Whayne TF Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631 [TBL] [Abstract][Full Text] [Related]
26. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Irwin JC; Khalesi S; Fenning AS; Vella RK Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224 [TBL] [Abstract][Full Text] [Related]
27. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium. Sposito AC; Faria Neto JR; Carvalho LS; Lorenzatti A; Cafferata A; Elikir G; Esteban E; Morales Villegas EC; Bodanese LC; Alonso R; Ruiz AJ; Rocha VZ; Faludi AA; Xavier HT; Coelho OR; Assad MH; Izar MC; Santos RD; Fonseca FA; Mello E Silva A; Silva PM; Bertolami MC; Curr Med Res Opin; 2017 Feb; 33(2):239-251. PubMed ID: 27776432 [TBL] [Abstract][Full Text] [Related]
28. Statin-Associated Side Effects. Thompson PD; Panza G; Zaleski A; Taylor B J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064 [TBL] [Abstract][Full Text] [Related]
29. Management of statin-intolerant patient. Arca M; Pigna G; Favoccia C Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565 [TBL] [Abstract][Full Text] [Related]
30. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL; J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study. Kereiakes DJ; Robinson JG; Cannon CP; Lorenzato C; Pordy R; Chaudhari U; Colhoun HM Am Heart J; 2015 Jun; 169(6):906-915.e13. PubMed ID: 26027630 [TBL] [Abstract][Full Text] [Related]
33. Advances in the management of statin myopathy. Gallo A; Perregaux J; Bruckert E Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129 [TBL] [Abstract][Full Text] [Related]
34. AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial. Desai NR; Kohli P; Giugliano RP; O'Donoghue ML; Somaratne R; Zhou J; Hoffman EB; Huang F; Rogers WJ; Wasserman SM; Scott R; Sabatine MS Circulation; 2013 Aug; 128(9):962-9. PubMed ID: 23884353 [TBL] [Abstract][Full Text] [Related]
35. No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial. Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR J Clin Lipidol; 2024; 18(2):e269-e284. PubMed ID: 38177036 [TBL] [Abstract][Full Text] [Related]